Insights Into the Seroprevalence, Clinical Spectrum, and Laboratory Features of Dengue and Chikungunya Mono-Infections vs. Co-infections During 2022–2023

Background Central India is hyperendemic for dengue and chikungunya virus infections, with yearly outbreaks being recorded. As these infections are clinically overlapping, co-infection of these viruses poses a diagnostic challenge. Therefore, it is imperative to identify them using serological or molecular tests. In this study, seroprevalence of dengue and chikungunya mono-infection as well as co-infections was estimated in suspected patients presented at our tertiary care center. Also, we compared the biochemical and other lab parameters of all the dengue and chikungunya mono-infected and co-infected IPD (Inpatient Department) patients. Methods A total of 3350 dengue and chikungunya suspected samples were recruited in this study. Sero-diagnosis of dengue was done using IgM MAC and NS-1 antigen enzyme-linked immunosorbent assay (ELISA), and chikungunya by IgM MAC ELISA. Further, we compared the demographic characteristics, temporal variations, clinical features, and biochemical parameters in patients with dengue and chikungunya mono-infection vs. co-infection. Results Seropositivity for dengue (DENV) and chikungunya (CHIKV) mono-infections was observed to be 23.86% (n=800) and 13.30% (n=444), respectively, while seropositivity for dengue and chikungunya co-infections was observed to be 6.55% (n=220). Leucopenia was significantly higher among the co-infected patients as compared to DENV and CHIKV mono-infected cases. Hypokalemia was significantly higher among the DENV patients and co-infected patients as compared to the CHIKV patients. Urea and creatinine levels were significantly elevated among the CHIKV patients as compared to DENV and co-infected patients. Conclusions Leucopenia and hypokalemia were found to be significantly high among the co-infected patients. Clinically suspected samples should be tested for both viruses, especially in the monsoon and post-monsoon seasons, as high sero-prevalence has been observed. Simultaneous diagnosis of these infections is required to diagnose dual infections and thus triage patients for monitoring and initiating supportive treatment to prevent fatal complications.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-09-15
DOI
https://doi.org/10.7759/cureus.92410
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Insights Into the Seroprevalence, Clinical Spectrum, and Laboratory Features of Dengue and Chikungunya Mono-Infections vs. Co-infections During 2022–2023

Deepti Chaurasia, Ankita Agarwal, Nagaraj Perumal, Garima Kapoor et al.
Cureus
Mosquito-borne diseases and control
article

Insights Into the Seroprevalence, Clinical Spectrum, and Laboratory Features of Dengue and Chikungunya Mono-Infections vs. Co-infections During 2022–2023

Deepti Chaurasia, Ankita Agarwal, Nagaraj Perumal, Garima Kapoor, Simmi Dube, Ishan Mewara, Harendra Pratap Singh Bundela
article en

Abstract

Background Central India is hyperendemic for dengue and chikungunya virus infections, with yearly outbreaks being recorded. As these infections are clinically overlapping, co-infection of these viruses poses a diagnostic challenge. Therefore, it is imperative to identify them using serological or molecular tests. In this study, seroprevalence of dengue and chikungunya mono-infection as well as co-infections was estimated in suspected patients presented at our tertiary care center. Also, we compared the biochemical and other lab parameters of all the dengue and chikungunya mono-infected and co-infected IPD (Inpatient Department) patients. Methods A total of 3350 dengue and chikungunya suspected samples were recruited in this study. Sero-diagnosis of dengue was done using IgM MAC and NS-1 antigen enzyme-linked immunosorbent assay (ELISA), and chikungunya by IgM MAC ELISA. Further, we compared the demographic characteristics, temporal variations, clinical features, and biochemical parameters in patients with dengue and chikungunya mono-infection vs. co-infection. Results Seropositivity for dengue (DENV) and chikungunya (CHIKV) mono-infections was observed to be 23.86% (n=800) and 13.30% (n=444), respectively, while seropositivity for dengue and chikungunya co-infections was observed to be 6.55% (n=220). Leucopenia was significantly higher among the co-infected patients as compared to DENV and CHIKV mono-infected cases. Hypokalemia was significantly higher among the DENV patients and co-infected patients as compared to the CHIKV patients. Urea and creatinine levels were significantly elevated among the CHIKV patients as compared to DENV and co-infected patients. Conclusions Leucopenia and hypokalemia were found to be significantly high among the co-infected patients. Clinically suspected samples should be tested for both viruses, especially in the monsoon and post-monsoon seasons, as high sero-prevalence has been observed. Simultaneous diagnosis of these infections is required to diagnose dual infections and thus triage patients for monitoring and initiating supportive treatment to prevent fatal complications.

CureusVol. 17(9)
Gandhi Medical College (IN)
Openalex Percentile: Top 66%
Mosquito-borne diseases and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.